Literature DB >> 7789641

Unchanged incidence of diabetic nephropathy in IDDM patients.

P Rossing1, K Rossing, P Jacobsen, H H Parving.   

Abstract

Recently, a dramatic decline in the cumulative incidence of diabetic nephropathy (< 10% after 25 years of diabetes) has been reported in insulin-dependent diabetes mellitus (IDDM) patients diagnosed before the age of 15 years between 1961 and 1980. In a clinic-based study, we assessed recent trends in the incidence of diabetic nephropathy. All 356 patients in whom IDDM was diagnosed before the age of 41 years between 1965 and 1979, identified in 1984, were followed until 1991 or until death. All patients were Caucasians and resided in Copenhagen. The cumulative incidences (life-table method) of diabetic nephropathy (urinary albumin excretion > or = 300 mg/24 h in two out of three consecutive samples) after 15 years of diabetes and in 1991 were 18 +/- 4 and 35 +/- 5% (cumulative incidence +/- SE; onset of diabetes 1965-1969, n = 113), 20 +/- 4 and 35 +/- 5% (onset of diabetes 1970-1974, n = 130), and 16 +/- 5% (onset of diabetes 1975-1979, n = 113), respectively (NS at 15 years). The prevalence of persistent microalbuminuria (31-299 mg/24 h) at time of follow-up was 24% (95% confidence interval: 16-33) in the group with onset of diabetes in 1965-1969, 28% (20-36) with onset of diabetes in 1970-1974, and 19% (13-28) with onset of diabetes in 1975-1979 (NS). The mean +/- SE HbA1c measured yearly beginning in 1984 was higher in patients with nephropathy (9.4 +/- 0.1%) and persistent microalbuminuria (8.9 +/- 0.1%) than in patients with normoalbuminuria (8.5 +/- 0.1%; P < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789641     DOI: 10.2337/diab.44.7.739

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

1.  Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study.

Authors:  M Nordwall; M Bojestig; H J Arnqvist; J Ludvigsson
Journal:  Diabetologia       Date:  2004-07-02       Impact factor: 10.122

Review 2.  Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history.

Authors:  Peter Rossing
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 3.  Type 1 diabetes in the young: the harvest of sorrow goes on.

Authors:  E A M Gale
Journal:  Diabetologia       Date:  2005-08       Impact factor: 10.122

Review 4.  [Possible genetic causes for late complications of diabetes mellitus].

Authors:  T Klemm; R Paschke
Journal:  Med Klin (Munich)       Date:  2000-01-15

Review 5.  The changing epidemiology of diabetic microangiopathy in type 1 diabetes.

Authors:  P Rossing
Journal:  Diabetologia       Date:  2005-06-29       Impact factor: 10.122

Review 6.  Risk predictors in patients with diabetic nephropathy.

Authors:  P Fioretto; M L Caramori; M Dalla Vestra; M Mauer
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

7.  Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).

Authors:  David M Nathan; Bernard Zinman; Patricia A Cleary; Jye-Yu C Backlund; Saul Genuth; Rachel Miller; Trevor J Orchard
Journal:  Arch Intern Med       Date:  2009-07-27

8.  Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice.

Authors:  Jinhua Li; Xinli Qu; John F Bertram
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

9.  The missing link: studying the alternative TGF-β pathway provides a unifying theory for different components of diabetic nephropathy.

Authors:  Xiaoyi Zheng; Vivek Bhalla
Journal:  Diabetes       Date:  2015-06       Impact factor: 9.461

10.  Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats.

Authors:  Ravi Prakash Rao; Ansima Singh; Arun K Jain; Bhartu Parsharthi Srinivasan
Journal:  J Biomed Res       Date:  2011-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.